T73549 |
RSH-7
|
2764609-97-2
|
98%
|
|
RSH-7 is a potent dual inhibitor of BTK and FLT3, with IC50s of 47 and 12 nM, respectively.RSH-7 has antiproliferative and antitumor activities, inducing apoptos...
|
T71857 |
GTP-14564
|
34823-86-4
|
98%
|
|
GTP-14564 is a novel tyrosine kinase inhibitor that also inhibits wt-FLT3 and ITD-FLT3. GTP-14564 inhibits the growth of interleukin-3-independent Ba/F1 expressi...
|
T34656 |
SKLB 1028
|
1350544-93-2
|
98%
|
|
SKLB1028 is a new type of oral multikinase inhibitor of EGFR, FLT3, and Abl. It shows excellent activity in FLT3-driven AML models and considerable potency in CM...
|
T27011 |
CHMFL-FLT3-122
|
1839150-56-9
|
98%
|
|
CHMFL-FLT3-122 is a potent and orally available FLT3 kinase inhibitor used to treat FLT3-ITD positive acute myeloid leukemia. CHMFL-FLT3-122 significantly suppre...
|
T73300 |
AXL-IN-13
|
2376928-82-2
|
98%
|
|
AXL-IN-13 is a potent and orally active AXL inhibitor with an IC50 value of 1.6 nM and a Kd value of 0.26 nM.AXL-IN-13 exhibits anticancer activity, reverses TGF...
|
T67754 |
(3Z)-5-(pyridin-3-yl)-3-[(1H-pyrrol-2-yl)methylidene]-2,3-dihydro-1H-indol-2-one
|
454234-24-3
|
98%
|
|
(3Z)-5-(pyridin-3-yl)-3-[(1H-pyrrol-2-yl)methylidene]-2,3-dihydro-1H-indol-2-one is a potent, selective and orally active FLT3 inhibitor, with IC50s of ∼40, 8, a...
|
T20742 |
TG-89
|
936091-56-4
|
98%
|
|
TG-89 is an inhibitor of JAK2, JAK3, RET and FLT3, and has an IC50 value of 11.2 μM against JAK2, showing anticancer activity in the treatment of ovarian and cer...
|
T64370 |
JI6
|
856436-16-3
|
98%
|
|
JI6 is a potent, selective and orally active FLT3 inhibitor. JI6 exhibits IC50s of ∼40, 8, and 4 nM for FLT3-WT, FLT3-D835Y, and FLT3-D835H, respectively. JI6 al...
|
T2653 |
SB1317
|
1204918-72-8
|
98%
|
|
SB1317 is a potent inhibitor of cyclin dependant kinases (CDKs), Janus kinase 2 (JAK2), and Fms-like tyrosine kinase-3 (FLT3).
|
T16995 |
TAS05567
|
1429038-15-2
|
98%
|
|
TAS05567 is a potent, highly selective, and ATP-competitive Syk inhibitor (IC50: 0.37 nM). TAS05567 only shows >70% inhibition of Syk and 4 other kinases (FLT3, ...
|
T12610L |
3-Hydroxy Midostaurin
|
179237-49-1
|
98%
|
|
3-Hydroxy Midostaurin (CGP 52421), a metabolite of PKC412, effectively inhibits FMS-like tyrosine kinase-3 (FLT3) autophosphorylation with IC50s of approximately...
|
T11731 |
JTV-519 free base
|
145903-06-6
|
98%
|
|
JTV-519 free base (K201 free base),Antiarrhythmic and cardioprotective properties. is a Ca2+-dependent blocker of sarcoplasmic reticulum Ca2+-stimulated ATPase (...
|
T6936 |
PF-03814735
|
942487-16-3
|
98%
|
|
PF-03814735 is a novel, potent and reversible inhibitor of Aurora A/B with IC50of 0.8 nM/5 nM, is less potent to Flt3, FAK, TrkA, and minimally active to Met and...
|
T10592 |
BPR1K871
|
2443767-35-7
|
98%
|
|
BPR1K871 is a potent and selective dual FLT3/AURKA inhibitor with IC 50 s of 19 nM and 22 nM for FLT3 and AURKA, respectively. BPR1K871 is a preclinical developm...
|
T6193 |
Dovitinib Dilactic Acid
|
852433-84-2
|
98%
|
|
Dovitinib Dilactic acid (TKI258 Dilactic acid) is the Dilactic acid of Dovitinib, which is a multitargeted RTK inhibitor, mostly for class III (FLT3/c-Kit) with ...
|
T14055 |
5Z-7-Oxozeaenol
|
253863-19-3
|
98%
|
|
5Z-7-Oxozeaenol, a natural anti-protozoan compound from fungal origin, acting as a potent irreversible and selective inhibitor of TAK1 and VEGF-R2, with IC50s of...
|
T11298 |
FLT3-IN-3
|
2229050-90-0
|
98%
|
|
FLT3-IN-3 is an effective FLT3 inhibitor, and the IC50s of FLT3 WT and FLT3 D835Y are 13 and 8 nM, respectively.
|
T7673 |
ATH686
|
853299-52-2
|
98%
|
|
ATH 686 is an potent and selective Inhibitor of FLT3.
|
T2341 |
KW-2449
|
1000669-72-6
|
98%
|
|
KW-2449 is a multiple-targeted inhibitor, mostly for Flt3 (IC50: 6.6 nM), modestly effective to Bcr-Abl, FGFR1, and Aurora A; little inhibitory on PDGFRβ, IGF-1R...
|
T20743 |
TG-46
|
936091-15-5
|
98%
|
|
TG-46 inhibits JAK2, FLT3, RET, JAK3 and can be used to study glaucoma.
|